selected publications
- Survival after Esophagectomy for Metastatic Esophageal Cancer: Should the Role of Surgery be Reconsidered?. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2025 Academic Article GET IT
- Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study. The Lancet. Oncology. 2025 Academic Article GET IT
- Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Review GET IT
- Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection. JCO precision oncology. 2025 Academic Article GET IT
-     
    
    
                     Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. 
 
                    Annals of surgical oncology. 
            
             2024
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 1
- Intra-operative pyloric BOTOX injection versus pyloric surgery for prevention of delayed gastric emptying after esophagectomy. Surgical endoscopy. 2024 Academic Article GET IT
- Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers. The oncologist. 2024 Academic Article GET IT
- Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Academic Article GET IT
- Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases. Journal of gastrointestinal oncology. 2024 Academic Article GET IT
-     
    
    
                     Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes. 
 
                    Annals of surgical oncology. 
            
             2024
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 3
- Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. Cancers. 2024 Academic Article GET IT
- RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab. Oncology. 2023 Academic Article GET IT
- Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma. Cancers. 2023 Academic Article GET IT
- FLOT or CROSS for gastroesophageal junction cancers-is the debate over yet?. Chinese clinical oncology. 2023 Review GET IT
-     
    
    
                     Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer. 
 
                    Annals of surgical oncology. 
            
             2023
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 8
-     
    
    
                     Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States. 
 
                    Current oncology (Toronto, Ont.). 
            
             2023
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 2
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Academic Article GET IT
- Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer-regional differences in efficacy. Annals of palliative medicine. 2022 Editorial Article GET IT
-     
    
    
                     Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma. 
 
                    The oncologist. 
            
             2022
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 2
- The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer. Journal of surgical oncology. 2022 Academic Article GET IT
-     
    
    
                     A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer. 
 
                    European journal of cancer. 
            
             2022
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 41
-     
    
    
                     Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. 
 
                    The oncologist. 
            
             2022
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 5
-     
    
    
                     Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis. 
 
                    Annals of surgery. 
            
             2021
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 20
-     
    
    
                     Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis. 
 
                    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 
            
             2021
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 2
-     
    
    
                     A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. 
 
                    British journal of cancer. 
            
             2021
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 30
-     
    
    
                     Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies. 
 
                    Expert opinion on investigational drugs.
            
             2021
             
			
			
			
			
			
			Review
 			GET IT
 			
 Times cited: 7
-     
    
    
                     Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers. 
 
                    Cancer. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 23
-     
    
    
                     Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer. 
 
                    Journal of medical imaging and radiation oncology. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 22
-     
    
    
                     Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis. 
 
                    Annals of surgery. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 19
-     
    
    
                     Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters?
              2020
  			GET IT
 			
 Times cited: 17
-     
    
    
                     Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program. 
 
                    The Journal of surgical research. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 1
-     
    
    
                     Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer. 
 
                    The Journal of surgical research. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 11
-     
    
    
                     Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery. 
 
                    Journal of gastrointestinal oncology. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 13
-     
    
    
                     Radiation-induced hepatitis masquerading as metastatic disease: the importance of correlating diagnostic imaging with treatment planning.
              2020
  			GET IT
 			
 Times cited: 3
-     
    
    
                     The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer. 
 
                    Cancer management and research.
            
             2020
             
			
			
			
			
			
			Review
 			GET IT
 			
 Times cited: 16
-     
    
    
                     An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol. 
 
                    Endoscopic ultrasound. 
            
             2020
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 26
-     
    
    
                     Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy.
              2019
  			GET IT
 			
 Times cited: 1
-     
    
    
                     Is Preoperative G-Tube Use Safe for Esophageal Cancer Patients?. 
 
                    Journal of the American College of Nutrition. 
            
             2019
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 4
-     
    
    
                     Predictive markers in gastric cancer immunotherapy treatment-are we there yet?. 
 
                    Translational gastroenterology and hepatology. 
            
             2019
             
			
			
			
			
			
			Editorial Article
 			GET IT
 			
 Times cited: 3
-     
    
    
                     Clinical characterization of colitis arising from anti-PD-1 based therapy. 
 
                    Oncoimmunology. 
            
             2018
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 54
-     
    
    
                     Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy. 
 
                    OncoTargets and therapy.
            
             2018
             
			
			
			
			
			
			Review
 			GET IT
 			
 Times cited: 8
-     
    
    
                     Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center. 
 
                    American journal of clinical oncology. 
            
             2017
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 3
-     
    
    
                     Cerebral fat embolism syndrome mimicking thrombotic thrombocytopenic purpura in a patient with hemoglobin SC disease. 
 
                    American journal of hematology.
            
             2016
             
			
			
			
			
			
			Conference Paper
 			GET IT
 			
 Times cited: 16
-     
    
    
                     Cancer Survivorship and Models of Survivorship Care: A Review. 
 
                    American journal of clinical oncology.
            
             2015
             
			
			
			
			
			
			Review
 			GET IT
 			
 Times cited: 38
-     
    
    
                     Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer. 
 
                    Journal of Cancer. 
            
             2014
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 9
-     
    
    
                     Thrombophilia testing in children: a 7 year experience. 
 
                    Pediatric blood & cancer. 
            
             2013
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 8
-     
    
    
                     Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. 
 
                    Breast cancer research and treatment. 
            
             2012
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 74
-     
    
    
                     Extrathoracic metastases of thymic origin: a review of 35 cases. 
 
                    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 
            
             2011
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 51
-     
    
    
                     PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. 
 
                    Journal of cell science. 
            
             2011
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 61
-     
    
    
                     Atypical ductal hyperplasia: interobserver and intraobserver variability. 
 
                    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 
            
             2011
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 97
-     
    
    
                     FOXA1 is an independent prognostic marker for ER-positive breast cancer. 
 
                    Breast cancer research and treatment. 
            
             2011
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 99
-     
    
    
                     High-level expression of forkhead-box protein A1 in metastatic prostate cancer. 
 
                    Histopathology. 
            
             2011
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 59
-     
    
    
                     Personalized medicine: the road ahead. 
 
                    Clinical breast cancer.
            
             2011
             
			
			
			
			
			
			Review
 			GET IT
 			
 Times cited: 40
-     
    
    
                     Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. 
 
                    Oncogene. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 110
-     
    
    
                     Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model. 
 
                    Oncology reports. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 23
-     
    
    
                     WHO types A and AB thymomas: not always benign. 
 
                    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 39
-     
    
    
                     ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. 
 
                    Cancer biology & therapy. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 14
-     
    
    
                     Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast. 
 
                    Journal of clinical pathology. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 9
-     
    
    
                     Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. 
 
                    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 50
-     
    
    
                     Conjunctival squamous cell carcinoma due to ocular prostheses: a case report and review of literature.
              2010
  			GET IT
 			
 Times cited: 9
-     
    
    
                     Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes. 
 
                    Breast cancer research and treatment. 
            
             2010
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 16
-     
    
    
                     Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. 
 
                    Breast cancer research and treatment. 
            
             2009
             
			
			
			
			
			
			Academic Article
 			GET IT
 			
 Times cited: 156
 
         